跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
AURO-AZITHROMYCIN - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
AURO-AZITHROMYCIN
Authorized
STANDARD
AURO-AZITHROMYCIN
auro pharma inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
bd02bd909d04c7ed
Company
auro pharma inc
Type
Standard
Approval Details
Approval Id
bd02bd909d04c7ed
Drug Approval Canada Name
AURO-AZITHROMYCIN
Product Name
AURO-AZITHROMYCIN
Status
Marketed
Status Date
2019-10-30
Original Market Date
2019-10-30
Din
02482371
Drug Class
Human
Dosage Form
Powder For Suspension
Route Of Administration
Oral
Schedule
Prescription
Ahfs
08:12.12.08
Atc Original
J01FA10 AZITHROMYCIN
Atc Name
j 01 fa 10
Aig Number
0126072003
Company Name
auro pharma inc
Company Address
3700 Steeles Avenue West, Suite 402, Woodbridge, Ontario, Canada, L4L 8K8
Active Ingredients
AZITHROMYCIN (AZITHROMYCIN DIHYDRATE)
200 MG / 5 ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
bd02bd909d04c7ed
Type
Standard
Back to Health Canada Approvals